GlassScriptPhysician profile
Jennifer Mchenry
NPI 1437561750
$5,556.99
in general payments reported to CMS, 2019-2025
22 companies · $544 in 2025
The $544 reported for 2025 was more than what 76% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,063 · 2022: $1,527 · 2023: $1,466 · 2024: $956 · 2025: $544.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,967.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,966.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,862.41 | 2021-2024 | Rybelsus, Ozempic, Wegovy |
| Abbvie INC. | $1,732.47 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $532.35 | 2022-2025 | Airsupra, Fasenra, Breztri |
| Vanda Pharmaceuticals INC. | $249.99 | 2024 | Fanapt |
| Xeris Pharmaceuticals, INC. | $213.07 | 2022-2023 | Gvoke Hypopen |
| Bayer Healthcare Pharmaceuticals INC. | $187.68 | 2022-2024 | |
| Lilly USA, LLC | $173.69 | 2021-2024 | Mounjaro, Reyvow, Emgality |
| Axsome Therapeutics, INC. | $119.12 | 2025 | Auvelity |
| Biohaven Pharmaceutical Holding Company LTD. | $101.58 | 2022 | |
| Pfizer INC. | $99.43 | 2023 | |
| Medtronic, INC. | $57.61 | 2023-2025 | Minimed 780g |
| Lundbeck LLC | $47.75 | 2023-2024 | Rexulti |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $25.38 | 2024 | Caplyta |
| Nevro Corp. | $24.95 | 2023 | Senza |
| Amarin Pharma, INC. | $19.72 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $17.57 | 2023 | Adlarity |
| Otsuka America Pharmaceutical, INC. | $17.01 | 2024 | Rexulti |
| Boston Scientific Corporation | $16.55 | 2023 | |
| Exact Sciences Corporation | $16.05 | 2023 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.36 | 2023 | Jardiance |
| Currax Pharmaceuticals LLC | $13.64 | 2021 | |
| Acadia Pharmaceuticals INC | $13.61 | 2025 | Nuplazid |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Mchenry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.